Acme United Corporation ACU R2K
Company Overview
Acme United Corporation supplies cutting, measuring, first aid, and sharpening products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally. The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimmers, safety cutters, lettering products, glue guns, and other craft products under the Westcott brand name; and cutting tools under the Clauss brand. It also provides sharpening knives, scissors, chisels, skis, skates, and other edges under the DMT brand. In addition, the company offers first aid kits and safety solutions under the First Aid Only brand; portable eyewash solution and over-the-counter medication, including active ingredients aspirin, acetaminophen, and ibuprofen under the PhysiciansCare brand; bodily fluid and spill clean-up solution under the Spill Magic brand; various first aid kit, refill, and safety supplies, including CPR kits, burn kits, and automotive and emergency first aid kits under the First Aid Central; first aid kits for the promotional products industry under Safety Made brand; alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, various antiseptic wipes under the Med-Nap brand, and Pac-Kit, as well as My Medic brands. It sells its products directly and through its independent manufacturer representatives to wholesale, contract, and retail stationery distributors; office supply superstores, mass market retailers, industrial and medical distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains, and wholesale florists, as well as through its websites. The company was formerly known as Acme Shear Company and changed its name to Acme United Corporation in 1971. Acme United Corporation was founded in 1867 and is based in Shelton, Connecticut.
Why Investors Should Care
Net profit has compounded at 49.7% per year over the last five years.
Trades at a P/E of 20.4, below the sector median of 20.6.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $196.54M (+1.1% YoY); net profit $10.18M.
- Trailing 12 Months Year-on-year growth — revenue +13.8%, earnings -41.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.4%, profit CAGR 49.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.44% |
| 1 Year: | 13.80% |
Compounded Profit Growth
| 5 Years: | 49.72% |
| 1 Year: | -41.50% |
Stock Price Performance
| 1 Year: | +12.06% |
| 6 Months: | +10.74% |
| 3 Months: | +4.92% |
| 1 Month: | +4.16% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)56.56 · Neutral
P/E of 20.38 is below the sector median of 20.61 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 49.7% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACU Acme United Corporation R2K | 47.29 | 20.38 | $180.19M | 1.41% | 9.91% | 8.46% | 0.44% | 49.72% |
| 2 | WMT Walmart Inc. SPX | 112.53 | 39.62 | $895.52B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 916.54 | 46.24 | $406.47B | 0.63% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 82.45 | 25.93 | $354.74B | 2.52% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPX | 148.05 | 21.64 | $344.75B | 2.92% | 22.93% | 31.11% | 0.36% | 1.66% |
| 6 | PM Philip Morris International Inc. SPX | 180.88 | 25.44 | $281.91B | 3.34% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPX | 135.40 | 17.75 | $184.96B | 4.37% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | MO Altria Group, Inc. SPX | 70.52 | 14.72 | $117.76B | 6.04% | 38.27% | - | 1.24% | -1.89% |
| 9 | MNST Monster Beverage Corporation NDXSPX | 97.57 | 47.14 | $95.42B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 27.75M | 38.85M | 33.78M | 30.17M | 31.71M | 39.75M | 34.73M | 31.13M | 31.37M | 40.22M | 36.99M | 33.87M | 35.77M | 44.04M | 43.32M | 43.52M | 44.85M | 47.92M | 43.33M | 56.77M | 49.74M | 45.84M | 53.34M | 50.38M | 44.96M | 55.42M | - | - | 45.96M | 54.00M | 49.06M | 47.52M | 52.30M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 28.04M | 31.85M | 29.87M | 29.38M | 31.52M |
| Gross Profit | 12.54M | 10.32M | - | 9.19M | 14.70M | 11.86M | 9.81M | 10.56M | 14.48M | 12.23M | 10.63M | 12.12M | 14.71M | 12.45M | 11.36M | 11.80M | 14.77M | 13.13M | 12.29M | 13.53M | 16.05M | 14.96M | 15.59M | 16.15M | 17.00M | 14.97M | 18.55M | 15.93M | 16.28M | 20.02M | 19.50M | 17.40M | 22.63M | - | - | 17.92M | 22.15M | 19.20M | 18.15M | 20.79M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.49M | 15.76M | 16.19M | 15.25M | 19.04M |
| Operating Income | 3.88M | 1.99M | - | 955.00K | 4.64M | 2.14M | - | 1.21M | 3.91M | 1.97M | - | 1.36M | 3.62M | 1.37M | - | 1.53M | 3.77M | 1.73M | - | 2.01M | 4.38M | 2.12M | 2.97M | 3.79M | 2.96M | 1.37M | 3.98M | 953.00K | 2.19M | 5.25M | 3.66M | 2.56M | 6.38M | - | - | 2.43M | 6.39M | 3.01M | 2.90M | 1.75M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.02M | 8.04M | 4.50M | 4.44M | 3.70M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 397.00K | 430.00K | 451.00K | 249.92K | 486.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.12M | 6.09M | 2.44M | 2.47M | 1.24M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 466.00K | 1.34M | 536.00K | 595.20K | 259.00K |
| Net Income | 2.71M | 1.21M | 440.00K | 565.00K | 3.27M | 1.47M | 545.00K | 659.00K | 2.85M | 1.20M | -655.00K | 764.00K | 2.44M | 807.00K | 591.00K | 807.00K | 2.67M | 1.06M | 978.00K | 1.28M | 3.20M | 1.58M | 2.05M | 7.23M | 2.05M | 830.00K | 2.74M | 64.00K | 990.00K | 3.44M | 2.15M | 1.64M | 4.45M | - | - | 1.65M | 4.75M | 1.90M | 1.88M | 985.00K |
| Diluted EPS | 0.74 | 0.33 | 0.11 | 0.16 | 0.91 | 0.40 | 0.15 | 0.18 | 0.75 | 0.32 | -0.16 | 0.21 | 0.67 | 0.23 | 0.17 | 0.24 | 0.77 | 0.30 | 0.29 | 0.36 | 0.92 | 0.46 | 0.52 | 1.82 | 0.50 | 0.22 | 0.71 | 0.02 | 0.28 | 0.96 | 0.58 | 0.39 | 1.09 | - | - | 0.41 | 1.16 | 0.46 | 0.46 | 0.24 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63.15M | 73.30M | 84.37M | 89.58M | 107.22M | 109.81M | 124.57M | 130.55M | 137.32M | 142.46M | 164.00M | - | 193.96M | 191.50M | 194.49M | 196.54M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 130.40M | 119.29M | 118.14M | 119.13M |
| Gross Profit | 23.37M | 26.32M | 29.75M | 31.82M | 38.19M | 39.56M | 45.56M | 47.90M | 50.65M | 52.00M | 59.59M | - | 63.56M | 72.21M | 76.35M | 77.41M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 57.29M | 59.02M | 62.21M | 62.69M |
| Operating Income | 2.98M | 4.28M | 5.36M | 5.88M | 7.39M | 7.35M | 8.44M | 7.88M | 7.46M | 8.43M | 11.41M | - | 6.27M | 13.19M | 14.14M | 14.72M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | 10.64M | 30.90M | 20.30M | 21.02M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 2.40M | 3.10M | 1.94M | 1.56M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | 3.66M | 22.73M | 12.29M | 13.12M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 627.68K | 4.94M | 2.27M | 2.93M |
| Net Income | 2.57M | 2.81M | 3.55M | 4.00M | 4.79M | 4.79M | 5.85M | 4.05M | 4.60M | 5.51M | 8.10M | - | 3.03M | 17.79M | 10.02M | 10.18M |
| Diluted EPS | 0.81 | 0.91 | 1.13 | 1.22 | 1.36 | 1.30 | 1.64 | 1.09 | 1.30 | 1.60 | 2.31 | - | 0.82 | 4.86 | 2.45 | 2.49 |
| R&D Expense | - | 535.50K | 572.99K | 602.99K | 665.00K | 690.00K | 750.00K | 752.00K | 734.00K | 596.00K | 251.00K | - | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 49.58M | 55.22M | 67.83M | 68.08M | 79.31M | 81.42M | 92.07M | 114.73M | 109.48M | 110.75M | 129.87M | - | 164.38M | 149.24M | 162.17M | 171.00M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | 105.60M | 92.02M | 95.46M | 96.20M |
| Cash & Equivalents | 6.52M | 6.60M | 7.85M | 9.75M | 11.64M | 2.29M | 2.43M | 5.91M | 9.34M | 4.41M | 6.82M | 4.17M | - | 6.10M | 4.80M | 6.40M | 3.60M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.33M | 55.47M | 56.25M | 59.85M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.60M | 26.23M | 28.24M | 29.10M |
| Total Liabilities | - | 24.23M | 27.45M | 36.96M | 33.07M | 39.88M | 38.24M | 45.95M | 64.79M | 57.15M | 55.04M | 67.15M | - | 85.35M | 51.34M | 55.19M | 53.39M |
| Current Liabilities | - | 9.22M | 8.70M | 11.73M | 9.88M | 15.36M | 11.94M | 12.82M | 16.78M | 13.36M | 16.58M | 20.20M | - | 22.13M | 26.01M | 22.87M | 22.87M |
| Long Term Debt | - | 13.52M | 17.57M | 24.32M | 22.91M | 24.15M | 25.91M | 32.94M | 43.45M | 40.28M | 33.24M | 38.77M | - | 60.61M | 23.39M | 27.47M | 21.28M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.83M | 25.93M | 32.84M | 28.72M |
| Total Equity | 24.54M | 25.35M | 27.77M | 30.87M | 35.01M | 39.43M | 43.18M | 46.12M | 49.94M | 52.33M | 55.70M | 62.72M | - | 79.03M | 97.90M | 106.98M | 117.61M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.08M | 5.19M | 5.30M | 5.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.14M | 2.06M | -1.27M | 6.48M | 4.65M | 1.08M | 8.86M | 4.81M | 4.48M | 14.70M | 5.72M | - | 2.89M | 28.90M | 11.98M | 18.23M |
| Investing Cash Flow | -1.05M | -4.17M | -2.29M | -2.97M | -15.19M | -1.91M | -8.81M | -14.38M | -3.23M | -1.68M | -13.95M | - | -14.23M | 7.43M | -12.94M | -12.30M |
| Financing Cash Flow | 2.31M | 3.43M | 5.39M | -1.61M | 1.31M | 1.14M | 3.47M | 12.91M | -6.05M | -10.61M | 5.29M | - | 14.28M | -38.44M | 2.00M | -8.88M |
| Capital Expenditure | -937.08K | -940.71K | -681.13K | -4.59M | -2.04M | -1.76M | -1.81M | -3.15M | -2.85M | -1.68M | -2.57M | - | -4.60M | -4.98M | -7.15M | -10.65M |
| Free Cash Flow | -2.07M | 1.12M | -1.95M | 1.88M | 2.61M | -676.99K | 7.05M | 1.66M | 1.62M | 13.02M | 3.15M | - | -1.71M | 23.92M | 4.83M | 7.58M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | 2.94M | -2.11M | 1.04M | -2.96M |
| Dividends Paid | 655.83K | 771.58K | 1.09M | 728.39K | 1.06M | 1.20M | 1.33M | 1.41M | 1.48M | 1.61M | 1.60M | 1.79M | 1.90M | 1.99M | 2.22M | 2.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 37.0% | 35.9% | 35.3% | 35.5% | 35.6% | 36.0% | 36.6% | 36.7% | 36.9% | 36.5% | 36.3% | - | 32.8% | 37.7% | 39.3% | 39.4% |
| Operating Margin % | 4.7% | 5.8% | 6.4% | 6.6% | 6.9% | 6.7% | 6.8% | 6.0% | 5.4% | 5.9% | 7.0% | - | 3.2% | 6.9% | 7.3% | 7.5% |
| Net Margin % | 4.1% | 3.8% | 4.2% | 4.5% | 4.5% | 4.4% | 4.7% | 3.1% | 3.3% | 3.9% | 4.9% | - | 1.6% | 9.3% | 5.2% | 5.2% |
| ROE % | 10.1% | 10.1% | 11.5% | 11.4% | 12.1% | 11.1% | 12.7% | 8.1% | 8.8% | 9.9% | 12.9% | - | 3.8% | 18.2% | 9.4% | 8.7% |
| ROCE % | 7.4% | 9.2% | 9.6% | 10.1% | 11.6% | 10.6% | 10.7% | 8.0% | 7.8% | 9.0% | 10.4% | - | 4.4% | 10.7% | 10.2% | 9.9% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ACU
Acme United Corporation Announces New Bank Facility
SHELTON, Conn., July 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced it has entered into a new $65 million syndicated credit facility with HSBC Bank USA, N.A. (HSBC) and City National Bank (CNB), a …
Acme United to Release Second Quarter 2026 Financial Results on July 23, 2026
SHELTON, Conn., July 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for the second quarter of 2026 on Thursday, July 23, 2026, at 6:30 AM Eastern Time. A conference call to discu…
Acme United Corporation Board Approves Cash Dividend
SHELTON, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 16 cents per share on its outstanding common stock. The dividend is payable on July 23, 202…
Sidoti Events, LLC's May Micro-Cap Virtual Conference
NEW YORK, NY / ACCESS Newswire / May 20, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Virtual Investor Conference taking place Wednesday …
Acme United to Participate in the Sidoti Micro Cap Virtual Conference
SHELTON, Conn., May 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that Acme United’s Chairman and Chief Executive Officer Walter C. Johnsen will participate in a fireside chat at the Sidoti Micro …
Are Consumer Discretionary Stocks Lagging Acme United (ACU) This Year?
Here is how Acme United Corporation. (ACU) and ASICS Corporation Unsponsored ADR (ASCCY) have performed compared to their sector so far this year.
ACU — Frequently Asked Questions
What is the current share price of Acme United Corporation (ACU)?
As of 2026-07-15 16:51 PDT, Acme United Corporation (ACU) trades at $47.29 on NYSE American. Its 52-week range is $35.12 to $48.78.
What is the market capitalisation of ACU?
Acme United Corporation (ACU) has a market capitalisation of $180.19M on NYSE American.
What is the P/E ratio of ACU?
ACU trades at a trailing price-to-earnings (P/E) ratio of 20.38. The industry average P/E is 20.61. Its price-to-book (P/B) ratio is 1.49.
Does ACU pay a dividend?
Acme United Corporation (ACU) currently offers a dividend yield of 1.41%.
What is the return on equity (ROE) of ACU?
ACU has a return on equity (ROE) of 8.46%. Its return on capital employed (ROCE) is 9.91%.
Is ACU a good stock to buy?
This page provides a data-driven analysis of Acme United Corporation (ACU), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.